Target intelligence / Profile preview

Cryptic RGDKGE epitope of denatured type I collagen (RGDKGE epitope)

Target
RGDKGE epitope
Molecular classification
Extracellular matrix protein fragment, Neoepitope
01

Overview

The cryptic RGDKGE epitope is a specific peptide sequence located within the alpha-chain of type I collagen that is inaccessible in the native, triple-helical conformation of the protein (Brooks et al., 1998). Exposure of this epitope occurs through biochemical denaturation or proteolytic degradation by matrix metalloproteinases (MMPs), such as MMP-2 and MMP-9, which are frequently upregulated in the tumor microenvironment and sites of chronic inflammation (Xu et al., 2001). Once exposed, the RGDKGE sequence functions as a high-affinity ligand for integrin alpha-v beta-3 (αvβ3), facilitating endothelial cell adhesion, migration, and proliferation necessary for angiogenesis (Hangai et al., 2002). Therapeutic strategies targeting this epitope, such as the monoclonal antibody TRC093 (HUIV26), aim to selectively disrupt these interactions to inhibit pathological vessel growth and tumor expansion while sparing healthy tissues where collagen remains intact (Tracon Pharmaceuticals). This selectivity offers a potential safety advantage over broad-spectrum anti-angiogenic agents by specifically targeting the remodeled extracellular matrix associated with disease states.

Other names
HUIV26 epitopeXL313 epitopeDenatured type I collagen neoepitopeCryptic collagen siteProteolyzed collagen epitope
02

Mechanism of action

Selective binding to the exposed RGDKGE motif prevents integrin alpha-v beta-3 mediated endothelial cell attachment to denatured collagen, inducing apoptosis and inhibiting angiogenesis.

03

Biological functions

AngiogenesisCell adhesionCell migrationEndothelial cell survivalTissue remodeling
04

Disease associations

CancerNeovascular age-related macular degenerationDiabetic retinopathyFibrosisInflammatory diseases
05

Safety considerations

Potential impairment of physiological wound healingImpact on normal tissue remodeling
06

Interacting drugs

TRC093 (HUIV26)

1 more in the full profile.

07

Biomarkers

Circulating denatured collagen fragmentsMMP-2 activity levelsMMP-9 activity levels

Beyond the preview

Go deeper on Cryptic RGDKGE epitope of denatured type I collagen (RGDKGE epitope).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cryptic RGDKGE epitope of denatured type I collagen (RGDKGE epitope).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call